News that has caught Rachael Babin’s eye this week
Browsing: Editor’s Choice
Bacteria in cancer unmasked: a closer look at our microscopic co-inhabitants
Researchers at the Netherlands Cancer Institute have compiled a detailed catalogue of bacteria living in…
ANZUP’s ENZA-p combination breakthrough for patients with metastatic castration-resistant prostate cancer
In a significant stride forward in treatment options for metastatic castration-resistant prostate cancer (mCRPC), a…
Ask Chat GPT about your radiation oncology treatment
Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be…
New AI model detects 90% of lymphatic cancer cases
Medical image analysis using AI has developed rapidly in recent years. Now, one of the…
World-class centre tackles sex and gender inequities in health and medicine
A new national research, policy and education centre to improve health outcomes for all Australians…
Association between historical housing discrimination and shortfalls in colon cancer treatment
A nationwide study of 196 cities in the United States, shows that housing discrimination from…
Coffee reduces mortality in people with intestinal cancer
Recent research published in the International Journal of Cancer indicates that individuals who have previously…
Ovarian Cancer Research Foundation announces $2.4 million in new funding
Today, three ovarian cancer research institutions have received significant funding from the Ovarian Cancer Research…
COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed
Prostate cancer diagnoses in 20,000 men could have been missed due to the COVID-19 pandemic,…
Bladder cancer trial SUBDUE-1 shows promising results using a sub-urothelial durvalumab injection
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) SUBDUE-1 trial, featured…